Skip to Main Content

WASHINGTON — Fewer doctors would have to wait for permission to prescribe addiction treatment drugs under new, bipartisan legislation being unveiled this week by two lawmakers on the House Energy and Commerce Committee.

Under a new bill authored by Reps. Paul Tonko (D-N.Y.) and David McKinley (R-W.Va.), the practice of “prior authorization,” in which insurers require doctors to seek approval before they can proceed with a prescription or procedure, would be banned in state Medicaid programs for addiction treatment medicines like buprenorphine.

advertisement

The bill comes amid part of a broader movement to expand addiction treatment as the overdose crisis continues to claim roughly 70,000 American lives each year. Experts universally view increasing availability for addiction medicines as critical to preventing future deaths.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.